BeyondSpring, Inc. - Ordinary Shares (BYSI): Price and Financial Metrics
BYSI Price/Volume Stats
| Current price | $1.64 | 52-week high | $4.00 |
| Prev. close | $1.73 | 52-week low | $0.78 |
| Day low | $1.50 | Volume | 100,927 |
| Day high | $1.96 | Avg. volume | 89,766 |
| 50-day MA | $2.19 | Dividend yield | N/A |
| 200-day MA | $2.23 | Market Cap | 64.01M |
BYSI Stock Price Chart Interactive Chart >
BeyondSpring, Inc. - Ordinary Shares (BYSI) Company Bio
BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies. The co is advancing its lead asset, Plinabulin, into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia.
BYSI Price Returns
| 1-mo | -31.38% |
| 3-mo | -12.30% |
| 6-mo | -38.69% |
| 1-year | 75.59% |
| 3-year | -88.52% |
| 5-year | -87.58% |
| YTD | 82.22% |
| 2023 | -52.13% |
| 2022 | -58.50% |
| 2021 | -62.87% |
| 2020 | -21.29% |
| 2019 | -17.33% |
Loading social stream, please wait...